Show MeYes, in the United States you can get a hearing aid without an audiologist, but only the over-the-counter (OTC) type approved by the FDA for adults with perceived mild to moderate hearing loss since October 2022. You can buy these devices online or in pharmacies with no prescription, no exam, and no professional fitting. Prescription hearing aids, which include behind-the-ear models for severe loss and all pediatric devices, still require a licensed professional. The distinction matters because the two categories differ in amplification ceiling, fitting method, and price by roughly USD 1,000 to USD 5,000.
What Actually Changed in October 2022
The FDA's final rule establishing the OTC hearing aid category took effect on October 17, 2022. Before that date, every hearing aid in the US was a prescription device. The rule created a new regulatory class with specific technical constraints: a maximum output of 111 dB SPL, a maximum gain of 16 dB below 2000 Hz and 25 dB above, and a requirement that the device be adjustable by the user without special tools.
The 111 dB output ceiling is the load-bearing number. It sits well below the amplification a prescription device can deliver, which is precisely why OTC aids are restricted to mild to moderate loss. A person with severe loss needs gain that an OTC device is legally forbidden to produce.
The change was economic as much as clinical. Traditional hearing aids averaged USD 4,700 per pair in 2022, per a widely cited Consumer Reports survey. OTC devices launched between USD 200 and USD 2,000, creating a tenfold price spread that pulled millions of untreated adults into the market.
The Mechanism: Why Fitting Matters More Than the Device
A hearing aid is not an amplifier in the ordinary sense. It is a frequency-shaped compressor. The device splits incoming sound into bands, applies gain per band, and limits the output so loud sounds do not exceed a comfort threshold. The fitting step sets those gains to match a person's audiogram.
Here is the non-obvious part: two people with identical audiograms can need different gain prescriptions because loudness perception depends on cochlear health, not just threshold detection. A prescription fitting uses real-ear measurement, a probe microphone placed in the ear canal, to verify the actual sound level reaching the eardrum. Without that verification, a device can be 10 to 15 dB off target even when the software says it is correct.
OTC devices handle this by replacing the audiogram with self-adjustment. You use a smartphone app to raise or lower volume and treble until speech sounds comfortable. That works for mild loss because the correction range is small. It degrades for moderate loss because the app cannot distinguish "too quiet" from "too loud in the wrong frequency band."
In plain terms: an OTC hearing aid is a competent amplifier tuned by you, while a prescription aid is tuned by a measurement.
OTC Versus Prescription: A Quantified Comparison
| Feature | OTC hearing aid | Prescription hearing aid |
|---|---|---|
| Who can buy | Adults 18+, self-assessed mild to moderate loss | Anyone, after professional evaluation |
| Professional required | None | Audiologist or hearing instrument specialist |
| Typical price per pair | USD 200 to USD 2,000 | USD 2,000 to USD 6,000 |
| Maximum output | 111 dB SPL (FDA limit) | No fixed ceiling; set to prescription target |
| Fitting method | Self-adjustment via app | Real-ear measurement against audiogram |
| Severe or profound loss | Not permitted | Appropriate |
| Pediatric use | Prohibited under 18 | Standard of care |
| Trial period | Varies; often 30 to 45 days | Often 30 to 60 days, state-dependent |
| Insurance coverage | Rarely covered | Sometimes covered; varies by plan |
The 111 dB ceiling and the USD 200-to-6,000 price band are the two numbers to hold in mind. They define the clinical and economic boundary of the OTC category.
Who Should Not Skip the Audiologist
Red flags mean stop and see a professional before buying anything. These are not optional cautions.
- Sudden hearing loss in one ear within the past three months, which is a medical emergency with a treatment window measured in days
- Hearing loss worse in one ear, or ringing in only one ear
- Ear pain, drainage, or a feeling of fullness that persists
- Dizziness or balance problems alongside the hearing change
- A history of professional noise exposure with asymmetric thresholds
- Any concern that the loss is moderate or worse, since OTC devices cannot legally correct it
Sudden sensorineural hearing loss is the highest-stakes entry on this list. Corticosteroid treatment started within 72 hours recovers hearing in a substantial fraction of cases; delayed treatment drops that recovery rate sharply. Buying an OTC aid for a sudden loss wastes the treatment window.
The Timeline: From Purchase to Working Device
| Stage | Typical duration | What happens |
|---|---|---|
| Online hearing screen | 5 to 15 minutes | App-based threshold check, self-reported |
| Purchase and shipping | 2 to 7 days | Device arrives pre-configured to a default profile |
| First fitting session at home | 30 to 60 minutes | App walkthrough, initial gain setting |
| Adaptation period | 2 to 4 weeks | Brain adjusts to amplified sound; many quit here |
| Follow-up adjustment | Weeks 3 to 6 | Fine-tune bands, swap dome sizes |
| Decision point | Within return window (30 to 45 days) | Keep, exchange, or return |
| Stabilized use | 6 to 8 weeks | Realistic speech-in-noise performance becomes clear |
The adaptation period is where most OTC returns happen. New users often report that their own voice sounds hollow or that background noise is overwhelming in week one. Both are normal and fade as the auditory system recalibrates, typically by week three. Quitting at day five is the single most common OTC failure mode.
Corrected Misconceptions
The most persistent myth is that OTC aids are "the same device" as prescription aids sold cheaper. They are not. The output ceiling is a legal constraint, not a marketing choice. A prescription aid reprogrammed to OTC limits would perform similarly, but the reverse is impossible.
A second misconception: that a smartphone hearing test can substitute for an audiogram. App-based screens estimate thresholds but cannot measure bone conduction, which distinguishes conductive from sensorineural loss. That distinction changes whether a hearing aid is even the right intervention. A conductive loss from wax impaction or middle-ear fluid may need a medical fix, not an amplifier.
A third, subtler error: assuming mild loss needs no treatment until it becomes moderate. Untreated mild hearing loss is associated with faster cognitive decline in longitudinal cohorts, though the causal direction remains debated. Treating early is reasonable; treating urgently is not established.
What to Actually Do
Start with a free or low-cost hearing screen, either online or at a pharmacy kiosk, to estimate severity. If the result suggests mild loss and you have no red flags, an OTC device is a defensible first purchase.
Choose a retailer with a documented return window of at least 30 days and a live fitting support line. Buy one device first, not a pair, and test it in your hardest listening environment, usually a noisy restaurant.
Log your experience for two weeks: note speech clarity, background noise, and any discomfort. Bring that log to a follow-up call or, if results are poor, to an audiologist for a diagnostic audiogram, which costs USD 100 to USD 300 without insurance.
If the OTC device helps but not enough, that is useful diagnostic information: it suggests your loss exceeds the mild-to-moderate range and a prescription fitting is warranted.
Limits of the Evidence
The OTC category is young. Long-term outcome data on speech-in-noise performance and user satisfaction beyond 12 months is still accumulating, and early studies show satisfaction rates comparable to entry-level prescription aids for mild loss but lower for moderate loss.
Self-fitting algorithms improve yearly but have not been validated against real-ear measurement in independent trials at scale. Treat vendor claims of "audiologist-quality fitting" as marketing until peer-reviewed comparison data exists.
The bottom line is a threshold question, not a loyalty question. OTC hearing aids work for mild to moderate loss in adults without red flags, at a fraction of prescription cost. For anything beyond that range, the audiologist remains the correct first stop, and no app has yet replaced the probe microphone.